Abstract:Background: Improving the neuronal yield from in vitro cultivated neural progenitor cells (NPCs) is an essential challenge in transplantation therapy in neurological disorders. In this regard, Ascorbic acid (AA) is widely used to expand neurogenesis from NPCs in cultures although the mechanisms of its action remain unclear. Neurogenesis from NPCs is regulated by the redox-sensitive WNT/β-catenin signaling pathway. We therefore aimed to investigate how AA interacts with this pathway and potentiates neurogenesis. Methods: Effects of 200 μM AA were compared with the pro-neurogenic reagent and WNT/β-catenin signaling agonist lithium chloride (LiCl), and molecules with antioxidant activities i.e. N-acetyl-L-cysteine (NAC) and ruthenium red (RuR), in differentiating neural progenitor ReNcell VM cells. Cells were supplemented with reagents for two periods of treatment: a full period encompassing the whole differentiation process versus an early short period that is restricted to the cell fate commitment stage. Intracellular redox balance and reactive oxygen species (ROS) metabolism were examined by flow cytometry using redox and ROS sensors. Confocal microscopy was performed to assess cell viability, neuronal yield, and levels of two proteins: Nucleoredoxin (NXN) and the WNT/β-catenin signaling component Dishevelled 2 (DVL2). TUBB3 and MYC gene responses were evaluated by quantitative real-time PCR. DVL2-NXN complex dissociation was measured by fluorescence resonance energy transfer (FRET). Results: In contrast to NAC which predictably exhibited an antioxidant effect, AA treatment enhanced ROS metabolism with no cytotoxic induction. Both drugs altered ROS levels only at the early stage of the differentiation as no changes were held beyond the neuronal fate commitment stage. FRET studies showed that AA treatment accelerated the redox-dependent release of the initial pool of DVL2 from its sequestration by NXN, while RuR treatment hampered the dissociation of the two proteins. Accordingly, AA increased WNT/β-catenin signaling output i.e. MYC mRNA level, whereas RuR attenuated it. Moreover, AA improved neurogenesis as much as LiCl as both TUBB3-positive cell yield and TUBB3 mRNA level increased, while NAC or RuR attenuated neurogenesis. Markedly, the neurogenesis outputs between the short and the full treatment with either NAC or AA were found unchanged, supporting our model that neuronal yield is altered by events taking place at the early phase of differentiation. Conclusions: Our findings demonstrate that AA treatment elevates ROS metabolism in a non-lethal manner prior to the NPCs commitment to their neuronal fate. Such effect stimulates the redox-sensitive DVL2 activation and WNT/β-catenin signaling response that would enhance the ensuing neuronal cell differentiation.

Vitamin A Regulates Neural Stem Cell Proliferation in Rats after Hypoxic-Ischemic Brain Damage Via RARɑ-mediated Modulation of the Β-Catenin Pathway

Vitamin A bio-modulates apoptosis via the mitochondrial pathway after hypoxic-ischemic brain damage

Vitamin A Deficiency Impairs Postnatal Cognitive Function Via Inhibition of Neuronal Calcium Excitability in Hippocampus.

Additional File 2 of Vitamin A Bio-Modulates Apoptosis Via the Mitochondrial Pathway after Hypoxic-Ischemic Brain Damage

All-trans Retinoic Acid Suppresses Apoptosis in PC12 Cells Injured by Oxygen and Glucose Deprivation Via the Retinoic Acid Receptor Α Signaling Pathway.

Valproate Promotes Survival of Retinal Ganglion Cells in a Rat Model of Optic Nerve Crush.

Retinoic Acid Prevents the Neuronal Damage Through the Regulation of Parvalbumin in an Ischemic Stroke Model

Adenovirus-mediated VEGF165 Gene Transfer Has Neuroprotective Effects in Neonatal Rats Following Hypoxic-Ischemic Brain Damage

Retinoic acid signaling and neuronal differentiation

The effects of retinoic acid on the expression of neurogranin after experimental cerebral ischemia.

Vitamin D Receptor Activation Influences NADPH Oxidase (NOX2) Activity and Protects Against Neurological Deficits and Apoptosis in a Rat Model of Traumatic Brain Injury.

Vitamin A supplementation ameliorates motor incoordination via modulating RORα in the cerebellum in a valproic acid-treated rat autism model with vitamin A deficiency

Effects of Rattin on Cognitive Ability and Expressions of B-Cell Lymphoma 2 (BCL-2)/BCL2 Associated X (bax) and Brain-Derived Neurotrophic Factor (BDNF) in Hippocampus of Rats with Vascular Dementia

In Vitro Characteristics of Valproic Acid and All-Trans-retinoic Acid and Their Combined Use in Promoting Neuronal Differentiation While Suppressing Astrocytic Differentiation in Neural Stem Cells

Effect of hippocampal L‑NBP on BDNF and TrkB expression and neurological function of vascular dementia rats.

Retinoic acid attenuates ischemic injury-induced activation of glial cells and inflammatory factors in a rat stroke model

Ascorbic acid alters cell fate commitment of human neural progenitors in a WNT/β-catenin/ROS signaling dependent manner

All-trans Retinoic Acid has Limited Therapeutic Effects on Cognition and Hippocampal Protein Expression After Controlled Cortical Impact

Neuroprotective Effects of Valproic Acid Following Transient Global Ischemia in Rats.

Activation of the AKT/GSK-3β/β-catenin pathway via photobiomodulation therapy promotes neural stem cell proliferation in neonatal rat models of hypoxic-ischemic brain damage

VEGF overexpression in transplanted NSCs promote recovery of neurological function in rats with cerebral ischemia by modulating the Wnt signal transduction pathway